← Back to Search

Behavioural Intervention

Standard Acupuncture / Moxibustion for Neuropathic Pain

N/A

Waitlist Available

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline rating of pain intensity after 6 wks of twice-wkly treatment sessions (the end of the treatment phase) and at weeks 9, 11 and 15 (the follow-up phase - determine change and sustainability)

Awards & highlights

Study Summary

This trial assesses the efficacy of novel non-pharmacologic pain management approaches to reduce HIV-related DSP pain and improve quality of life.

Eligible Conditions

Neuropathic Pain
Pain
Neuropathy
HIV/AIDS

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline rating of general health after 6 wks of twice-wkly treatment sessions (the end of the treatment phase) and at weeks 9, 11 and 15 (the follow-up phase - determine change and sustainability)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline rating of general health after 6 wks of twice-wkly treatment sessions (the end of the treatment phase) and at weeks 9, 11 and 15 (the follow-up phase - determine change and sustainability)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline rating of general health after 6 wks of twice-wkly treatment sessions (the end of the treatment phase) and at weeks 9, 11 and 15 (the follow-up phase - determine change and sustainability) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gracely Pain Scale (GPS)

Secondary outcome measures

Clinical Global Severity Improvement Scale (CGIs)

Medical Outcome Survey - HIV (MOS-HIV)

NIH PROMIS Pain Scale

+2 more

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Standard (fixed) protocol Acu/Moxa - ActiveExperimental Treatment1 Intervention

Standard (Fixed) Acupuncture / Moxibustion Active Protocol Subjects receive active standard Acu/Moxa protocol aimed at reducing neuropathic pain/discomfort.

Group II: Individualized (tailored) protocol Acu/Moxa - ActiveExperimental Treatment1 Intervention

Individualized (Tailored) Active Acupuncture / Moxibustion Protocol Subjects receive active individualized Acu/Moxa protocol based on traditional Chinese medicine assessment aimed reducing neuropathic pain/discomfort.

Group III: Sham Acu/Placebo Moxa (Control)Active Control1 Intervention

Sham Acu/Placebo Moxa (Control) Note. All subjects randomized to the Control will be offered 12 active protocol acupuncture/ moxibustion treatments, at no cost, at the end of their study participation.

Group IV: WaitList (Control)Active Control1 Intervention

WaitList (Control) No treatment. Subjects receive all aspects of study participation with the exception of exposure to Acupuncture / Moxibustion. Note. All subjects randomized to the Control will then be offered 12 active protocol acupuncture/ moxibustion treatments, at no cost, at the end of their study participation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor

226 Previous Clinical Trials

314,059 Total Patients Enrolled

1 Trials studying Neuropathic Pain

44 Patients Enrolled for Neuropathic Pain

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,392 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for individuals to join this medical experiment at present?

"At present, clinicaltrials.gov confirms that the trial is actively recruiting. This venture was first announced on January 14th 2019 and its most recent update occurred October 26th 2021."

Answered by AI

What is the scope of this research's participants?

"Affirmative. The clinical trial directory on clinicaltrials.gov demonstrates that this medical study, initially published on January 14th 2019, is actively seeking patients. Thus far they have enlisted 196 participants from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain

Joyce K. Anastasi 2019. "Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03855111.

All > Nerve Pain